Tetracosactide (ACTH1-24)

Tetracosactide (ACTH 1-24) (Zyntex) is a synthetic polypeptide used as a diagnostic agent to assess adrenocortical function and for treating specific corticosteroid-responsive conditions.

SKU: 16960-16-0 Category: Tag:
Description
Tetracosactide (ACTH 1-24) is a synthetic polypeptide consisting of the first 24 amino acids of the naturally occurring adrenocorticotropic hormone. Zyntex supplies this premium active pharmaceutical ingredient for the global clinical diagnostics and specialized therapeutic sectors. This high-purity peptide (CAS 16960-16-0) stimulates the adrenal cortex to produce glucocorticoids and mineralocorticoids. It acts as a primary agent for evaluating adrenal reserve. In addition, it exhibits fewer allergic reactions compared to natural ACTH extracts. Therefore, medical professionals choose Tetracosactide (ACTH 1-24) for the “short ACTH stimulation test” and acute inflammatory therapies.

Tetracosactide (ACTH 1-24) Product Overview

Maximum diagnostic precision provides a major advantage in endocrinology. Tetracosactide (ACTH 1-24) effectively triggers the release of cortisol, allowing clinicians to identify primary adrenal insufficiency or Addison’s disease. This feature makes it the gold standard for diagnostic screening in hospitals and specialized laboratories. For instance, its rapid onset of action allows for results to be interpreted within 30 to 60 minutes. Consequently, it supports faster patient management decisions. As a result, Zyntex produces Tetracosactide (ACTH 1-24) with exceptional peptide purity, ensuring total stability in sterile injectable formulations.

Moreover, Zyntex provides research-grade peptides for advanced studies in hypothalamic-pituitary-adrenal (HPA) axis regulation. This application allows for the development of new treatments for infantile spasms and multiple sclerosis exacerbations. It pushes the boundaries of modern neurology and immunology. At the same time, pharmaceutical formulators value its role in developing sustained-release depot injections. In short, our product serves as a dependable “synthetic ACTH analog.” It supports both clinical diagnostic markets and specialized neurological research. Recently, interest in Tetracosactide (ACTH 1-24) for managing nephrotic syndrome has grown, highlighting its diverse therapeutic potential.

Tetracosactide (ACTH 1-24) Key Applications

This high-performance synthetic peptide is vital in these four specialized sectors:

🏥 Clinical Diagnostics

It is the primary active for ACTH stimulation tests. Thus, it provides consistent results for diagnosing adrenal disorders.

🧠 Neurology

It serves as a therapeutic agent for infantile spasms. Consequently, it helps manage severe pediatric seizure disorders.

🧪 Endocrine Research

It works as a key tool for HPA axis mapping. Undoubtedly, it is essential for studying corticosteroid feedback loops.

🔬 Pharma Formulation

It acts as a primary active for sterile liquids. Specifically, it aids in formulating stable, high-efficacy injectable drugs.

Technical Specifications

ParameterStandard Value
Product NameTetracosactide (ACTH 1-24)
Purity (HPLC)≥ 98.0%
Molecular FormulaC136H210N40O31S
CAS Number16960-16-0

⚠️ Usage Note: Tetracosactide (ACTH 1-24) must be stored under refrigeration ($2°C$ to $8°C$) and protected from light to maintain peptide stability. Therefore, ensure a validated cold chain during transport and storage to prevent degradation.